Information  X 
Enter a valid email address

GSK Plc (GSK)

  Print          Annual reports

Wednesday 25 May, 2022

GSK Plc

Director/PDMR Shareholding

GSK plc (the ‘Company’)

Transaction notification

1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Dr H Barron
b) Position/status Chief Scientific Officer and President, R&D
c) Initial notification/
amendment
Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument American Depositary Shares (‘ADSs’)

ISIN: US37733W1053
b) Nature of the transaction Acquisition of notional ADSs within Dr Barron’s GSK Executive Supplemental Savings Plan account.
 
c) Price(s) and volume(s) Price(s) Volume(s)
$44.7500 1,151.020
d) Aggregated information N/A (single transaction)
Aggregated volume Price
e) Date of the transaction 2022-05-23
f) Place of the transaction New York Stock Exchange (XNYS)

a d v e r t i s e m e n t